Andy Johnson is a litigator who enjoys helping his clients find solutions to their complex business problems. Sometimes these problems can only be solved through a jury’s verdict and the review of an appellate court (see Thomas Jefferson Foundation, Inc. v. Jordan, 2016 WL 661794, -- So. 3d -- (Ala.)). Other times these problems are resolved through a court’s intervention making a trial unnecessary (see Moore Oil Co, Inc. v D&D Oil Co., Inc., 747 F.Supp.2d 1280 (N.D. Ala. 2010), or through arbitration, mediation, or settlement. Andy believes that each case is different, and there is no one-size-fits-all approach to a business or legal problem.
Andy has worked with clients to resolve their specific legal issues in a variety of business areas. A significant portion of Andy’s practice has consisted of the defense of claims against companies that invent, design, manufacture and market complex products, with a focus on pharmaceutical or drug and device litigation. As an example, Andy was appointed as the co-defense liaison counsel in In Re Chantix (Varenicline) Products Liability Litigation MDL 2092. His work in the life sciences arena has encompassed the representation of Pfizer, Bayer, Merck and Guidant among others, and has spanned over 15 years.
Andy’s work for manufacturers has also involved tires (Cooper Tire and Goodyear) and construction materials (Valmont Newmark). This representation has spanned many aspects of litigation, from defense of product liability claims to protection of trade secrets and commercial disputes with other corporations.
Andy’s experience in the business and commercial context has involved the representation of a wide variety of industries in trial work, ranging from financial services companies (Signature Holdings Group, Inc., et al. v. Embry, Missouri Court of Appeals for the Southern District, Case No. SD31525; jury verdict affirmed on appeal), to hardwood flooring manufacturers (Cahow v. Armstrong Wood Products, Inc., CV-2003-136 (Circuit Court of Coffee County, Ala.; jury verdict).